THAMAR PERRY: Open Payments
NPI 1093218646 · MONONGAHELA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 15 payments from 8 companies in 2025. Trend: 2023 $58 · 2024 $263 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $55 |
| Madrigal Pharmaceuticals | 3 | $51 |
| Amgen Inc. | 2 | $41 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $40 |
| Lilly USA, LLC | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Acella Pharmaceuticals, LLC | 1 | $17 |
Products named: FREESTYLE LIBRE 3, REZDIFFRA, REPATHA, LifeVest, JARDIANCE, FARXIGA, LEQVIO, NP Thyroid 60.
Industry payments across PA — which companies pay providers there.
